AZ resumes trial of COVID-19 vaccine
The Pharma Data
SEPTEMBER 14, 2020
. AstraZeneca has confirmed that clinical trials assessing its Oxford University partnered coronavirus vaccine AZD1222 have resumed in the UK, following a green light by the Medicines Health Regulatory Authority (MHRA). Source link. Source link.
Let's personalize your content